BioSpace News Archive

Recently acquired subsidiary Alef Biotechnology officially renamed Tilray Latin America

Collaboration brings together Schrödinger’s in silico discovery capabilities with SPARC’s novel insights into CNS pathways to speed drug development

ARQ 531 demonstrates anti-tumor activity and favorable safety profile

HitGen Ltd today announced that it has entered into a drug discovery research collaboration with Genentech to identify potential small molecule leads against targets of interest to Genentech.

Clarivate Analytics list honors Dr. Luigi Franchi and Dr. Eicke Latz as most highly cited scientists, ranking in the top one percent globally

George Clinical has continued its involvement and collaboration with the Heart Health Research Center (HHRC), further developing the depth and quality of investigator networks.

The company signed an exclusive worldwide options and licensing agreement with Japanese giant ‘Astellas Pharma’ for the development and acquisition of Juventas’s technological applications - contingent on clinical trial milestone successes

ZANTHOSYN® #1 AT GNC STORES IN HAWAII FOR PAST 12 MONTHS

Subsidiaries Align as Unified Brand to Deliver Better Outcomes for All

Bayer announced today that the Food and Drug Administration (FDA) granted Breakthrough Device Designation to the Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Artificial Intelligence (AI) Pattern Recognition Software, which Bayer is currently developing jointly with Merck, known as MSD outside the U.S. and Canada.